PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 5, 2026Cancer Research0 citations

Abstract 6122: Organ-specific immune and metabolic programs shape spatial microenvironments in MSS colorectal cancer metastases

View Full Paper
JYJian YeCEColt A. EgelstonCWChongkai Wang

Key Points

  • This research aims to explore how organ-specific characteristics shape the immune and metabolic environments in metastatic colorectal cancer.
  • Applied high-plex spatial transcriptomic and proteomic techniques to analyze 70 tissue specimens from various regions of mCRC.
  • Used GeoMx WTA for spatial transcriptomic profiling and a 56-plex CODEX panel for spatial proteomic analysis.
  • Characterized microenvironmental programs across malignant, stromal, and marginal regions.
  • Malignant regions from different organs show distinct transcriptional clustering from normal tissue.
  • Liver metastases are marked by significant metabolic activity including lipid and amino acid metabolism.
  • Lung metastases are characterized by strong immune activity, while peritoneal metastases present a lipid-rich but immune-poor environment.

Abstract

Abstract Background: Our previous spatial analysis of MSS metastatic colorectal cancer (mCRC) revealed organ-specific differences in immune infiltration across metastatic sites (Ye et al., Cancer Res Commun, 2023). Building on that work, we expanded the cohort and applied high-plex spatial transcriptomic and proteomic platforms to characterize region- and organ-dependent microenvironmental programs. Methods: Spatial transcriptomic profiling using the GeoMx WTA (70 specimens) was performed across malignant, stromal, invasive-margin, distal, and TLS-associated regions. A 56-plex CODEX spatial proteomic panel (120 specimens) was used for whole-tumor multiplex imaging to visualize immune and stromal architecture. Results: Spatial compartment was the primary driver of transcriptional variation, with malignant epithelial regions from different organs clustering closely together and separating distinctly from normal colon villus epithelium and stroma. Liver outer-margin and distal regions formed a separate transcriptomic cluster from analogous regions in other organs, indicating a strong liver-associated imprint. Within this region-defined structure, GSEA revealed coherent organ-specific archetypes. Primary colon generally showed intermediate immune and metabolic programs. Liver metastases showed broad metabolic activation across regions, including lipid and amino-acid metabolism, mitochondrial and peroxisomal activity, and complement-related signatures, reflecting a metabolically conditioned liver niche. Lung metastases were associated with immune-enriched stromal, margin, and distal regions, marked by strong NK-cell cytotoxicity, T cell differentiation, cytokine signaling, mucosal-like immune networks, and antiviral pathways. Peritoneal metastases showed metabolically and immunologically quiet tumor cores, while outer and distal regions were enriched for lipid and steroid metabolism, and ECM and mesothelial activation, consistent with a lipid-rich, immune-poor peritoneal niche. Preliminary CODEX observations were broadly consistent with these patterns. Lung metastases often showed abundant T-cell infiltration; liver metastases showed lymphocytes accumulating at tumor boundaries with myeloid-enriched tumor centers; and peritoneal metastases displayed dense stromal or fibrotic architecture with limited intratumoral lymphocytes. Conclusions: High-plex spatial profiling reveals distinct organ-imposed microenvironmental programs in MSS mCRC. Liver metastases adopt a highly metabolic and complement-associated niche, lung metastases display strong peritumoral immune activity, and peritoneal metastases develop within a lipid-rich but immune-low environment. These findings highlight how each organ shapes metastatic ecology and may guide site-adapted therapeutic strategies. Citation Format: Jian Ye, Colt A. Egelston, Chongkai Wang, Marwan Fakih. Organ-specific immune and metabolic programs shape spatial microenvironments in MSS colorectal cancer metastases abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 6122.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ye et al. (2026) studied this question.

synapsesocial.com/papers/69d1fdb0a79560c99a0a3da3https://doi.org/10.1158/1538-7445.am2026-6122
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract 1272: Spatial profiling of human colorectal cancer brain metastasis identifies chromosomal instability with adaptive niche cellular reorganization and reprograming2024
  2. 2Abstract 1160: Investigating spatial gene expression profiling in colorectal cancer: Tumor and stroma comparison between primary lesions and matched liver metastases2024
  3. 3Abstract 6662: Spatial genomics reveals microenvironmental programs associated with organ-specific metastatic propensity in prostate cancer2026
  4. 4Abstract 6116: Spatial multi-omics dissection of colorectal cancer micrometastasis2026
  5. 5Abstract 3786: Genomic and transcriptomic characterization of peritoneal, lung and liver metastases of colorectal carcinoma reveals site-specific differences2024